knowledge -WSS

knowledge

author：hotspot 2025-09-29 16:21:01 - browse：94

WASHINGTON, DC - NOVEMBER 27: U.S. President Joe Biden speaks about supply chain resilience during an event in the Indian Treaty Room at the Eisenhower Executive Office Building on November 27, 2023 in Washington, DC. — President Biden spoke about supply chain resilience and drug shortages. Alex Wong/Getty Images

WASHINGTON — President Biden’s new plan to curb drug shortages by boosting domestic drug production won’t expand the supply of the chemotherapies that are currently in shortage, an administration official confirmed. The limited scope surprised experts, who told STAT Biden could have included those drugs in the effort.

The 15 cancer drugs in short supply account for only a little more than 10% of the drugs on FDA’s shortage list. But chemotherapies are far more crucial than many other drugs experiencing shortages, which include injections of amino acids and multivitamins, and sterile water. Gut-wrenching stories about cancer patients being switched to less-effective drugs have caused cancer doctors to agitate for government solutions.

Biden announced last week that he plans to use the Defense Production Act to get companies to make essential medicines and their ingredients in the United States. The administration will spend $35 million to boost domestic production of key starting materials for drugs that hospitals commonly use and are prone to shortages.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen
Next article： FDA approves updated Covid vaccines

WSS

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

FDA reorg will put new emphasis on investigations, sources say

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

Ventyx halts psoriasis drug development after lackluster trial results

IRA could hurt research into orphan drugs for rare diseases

After decades in use, heart stents finally beat placebo

focus

knowledge

knowledge

Apple is now the first public company to be valued at $3 trillion

FDA panel endorses Alnylam’s heart drug — after picking it apart

DIEP, the 'gold standard' of breast reconstruction, is under threat

IRA could hurt research into orphan drugs for rare diseases

Hollywood unions extend contract negotiations for actors

FDA reorg will put new emphasis on investigations, sources say

Cancer drug shortages should be causing more outrage

Study suggests Covid rebound is far more common with Paxlovid than without

Cancer drug shortages should be causing more outrage

How housing is health care on Long Island

hotspot

Pig kidney works a record two months in donated body

A letter from the executive editor: STAT UnitedHealth investigation

FDA approves updated Covid vaccines

Ventyx halts psoriasis drug development after lackluster trial results

Hospitals consider fixing cancer drug shortages on their own

Regeneron agrees to White House price limits on anti

knowledge

explore

entertainment

focus